Biomedical Engineering Reference
In-Depth Information
195. Goldberg DJ. Photodynamic therapy in skin rejuvenation. Clin Derma-
tol 2008; 26: 608-613.
196. Lee WR, Tsai RY, Fang CL, et al. Microdermabrasion as a novel tool to
enhance drug delivery via the skin: an animal study. Dermatol Surg
2006; 32: 1013-22.
197. Katz BE, Truong S, Maiwald DC, Frew KE, George BA. Effi cacy of micro-
dermabrasion preceding ALA application in reducing the incubation
time of ALA in laser PDT. J Drugs Dermatol 2007; 6: 140-2.
198. Morton S, Campbell S, Gupta G, et al. Intraindividual, right-left com-
parison of topical methyl aminolaevulinate photodynamic therapy and
cryotherapy in subjects with actinic keratosis: a multicentre, random-
ized controlled study. Br J Dermatol 2006; 155: 1029-36.
199. Harper JC. An update on the pathogenesis and management of acne vul-
garis. J Am Acad Dermatol 2004; 51:s36-8.
200. Herane MI, Ando I. Acne in infancy and acne genetics. Dermatology
2003; 206: 24-8.
201. Strauss JS, Leyden JJ, Lucky AW, et al. A randomized trial of the effi cacy
of a new micronized formulation versus a standard formulation of
isotretinoin in patients with severe recalcitrant nodular acne. J Am Acad
Dermatol 2001; 45: 187-95.
202. Layton AM, Knaggs H, Taylor J, Cunliffe WJ. Isotretinoin for acne vul-
garis—10 years later: a safe and successful treatment. Br J Dermatol
1993; 129: 292-6.
203. Quereux G, Volteau C, N'Guyen JM, Dreno B. Prospective study of risk
factors of relapse after treatment of acne with oral isotretinoin. Derma-
tology 2006; 212: 168-76.
204. Zouboulis CC. The truth behind this undeniable effi cacy—recurrence
rates and relapse risk factors of acne treatment with oral isotretinoin.
Dermatology 2006; 212: 99-100.
205. Zane LT, Leyden WA, Marqueling AL, Manos MM. A population-based
analysis of laboratory abnormalities during isotretinoin therapy for acne
vulgaris. Arch Dermatol 2006; 142: 1016-22.
206. DiGiovanna JJ, Langman CB, Tschen EH, et al. Effect of a single course
of isotretinoin therapy on bone mineral density in adolescent patients
with severe, recalcitrant, nodular acne. J Am Acad Dermatol 2004; 51:
709-17.
207. Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and
suicide in patients treated with isotretinoin. J Am Acad Dermatol 2001;
45: 515-19.
208. Hongcharu W, Taylor CR, Chang Y, et al. Topical ALA-photodynamic
therapy for the treatment of acne vulgaris. J Invest Dermatol 2000; 115:
183-92.
209. Pollock B, Turner D, Stringer MR, et al. Topical aminolaevulinic acid-
photodynamic therapy for the treatment of acne vulgaris: a study of
clinical effi cacy and mechanism of action. Br J Dermatol 2004; 151:
616-22.
210. Ashkenazi H, Malik Z, Harth Y, Nitzan Y. Eradication of Propionibacte-
rium acnes by its endogenic porphyrins after illumination with high
intensity blue light. FEMS Immunol Med Microbiol 2003; 35: 17-24.
211. Hongcharu W, Taylor CR, Chang Y, et al. Topical ALA-photodynamic
therapy for the treatment of acne vulgaris. J Invest Dermatol 2000; 115:
183-92.
212. Itoh Y, Ninomiya Y, Tajima S, Ishibashi A. Photodynamic therapy of acne
vulgaris with topical delta-aminolaevulinic acid and incoherent light in
Japanese patients. Br J Dermatol 2001; 144: 575-9.
213. Taub AF. Photodynamic therapy for the treatment of acne: a pilot study.
J Drugs Dermatol 2004; 3: S10-14.
214. Goldman MP, Boyce SM. A single-center study of aminolevulinic acid
and 417 nm photodynamic therapy in the treatment of moderate to
severe acne vulgaris. J Drugs Dermatol 2003; 2: 393-4.
215. Akaraphanth R, Kanjanawanitchkul W, Gritiyarangsan P. Effi cacy of
ALA-PDT vs blue light in the treatment of acne. Photodermatol Photo-
immunol Photomed 2007; 23: 186-90.
216. Gold MH, Bradshaw VL, Boring M, et al. The use of a novel intense
pulsed light and heat source and ALA-PDT in the treatment of moderate
to severe infl ammatory acne vulgaris. J Drugs Dermatol 2004; 3: S15-16.
217. Gold MH, Biron JA, Boring M, Bridges TM, Bradshaw VL. Treatment of
moderate to severe infl ammatory acne vulgaris: photodynamic therapy
with 5-aminolevulinic acid and a novel advanced fl uorescence technol-
ogy pulsed light source (Clinical report). J Drugs Dermatol 2007; 6:
319-22.
218. Rojanamatin J, Choawawanich P. Treatment of infl ammatory facial
acne vulgaris with intense pulsed light and short contact of topical
5-aminolevulinic acid: a pilot study. Dermatol Surg 2006; 32: 991-7.
219. Santos MAV, Belo VG, Santos G. Effectiveness of photodynamic therapy
with topical 5-aminolevulinic acid and intense pulsed light versus
intense pulsed light alone in the treatment of acne vulgaris: comparative
study. Dermatol Surg 2005; 31: 910-15.
220. Taub AF. A comparison of intense pulsed light, combination radiofre-
quency and intense pulsed light, and blue light in photodynamic therapy
for acne vulgaris. J Drugs Dermatol 2007; 6: 1010-16.
221. Yeung CK, Shek SY, Bjerring P, et al. A comparative study of intense pulsed
light alone and its combination with photodynamic therapy for the treat-
ment of facial acne in Asian skin. Lasers Surg Med 2007; 39: 1-6.
222. Oh SH, Ryu DJ, Han EC, Lee KH, Lee JH. A comparative study of topical
5-aminolevulinic acid incubation times in photodynamic therapy with
intense pulsed light for the treatment of infl ammatory acne. Dermatol
Surg 2009; 35: 1918-26.
223. Haedersdal M, Togsverd-Bo K, Wiegell SR, et al. Long-pulsed dye laser
versus long-pulsed dye laser-assisted photodynamic therapy for acne
vulgaris: a randomized controlled trial. J Am Acad Dermatol 2008; 58:
387-94.
224. Alexiades-Armenakas M. Long-pulsed dye laser-mediated photody-
namic therapy combined with topical therapy for mild to severe come-
donal, infl ammatory, or cystic acne. J Drugs Dermatol 2006; 5: 45-56.
225. Hong S-B, Lee M-H. Topical aminolevulinic acid-photodynamic ther-
apy for the treatment of acne vulgaris. Photodermatol Photoimmunol
Photomed 2005; 21: 322-5.
226. Hörfelt C, Funk J, Frohm-Nilsson M, et al. Topical methyl aminolaevu-
linate photodynamic therapy for treatment of facial acne vulgaris: results
of a randomized, controlled study. Br J Dermatol 2006; 155: 608-13.
227. Wiegell SR, Wulf HC. Photodynamic therapy using 5-aminolevulinic acid
versus methyl aminolevulinate. J Am Acad Dermatol 2006; 54: 647-51.
228. Wiegell SR, Wulf HC. Photodynamic therapy of acne vulgaris using
methyl aminolaevulinate: a blinded, randomized, controlled trial. Br J
Dermatol 2006; 154: 969-76.
229. Hörfelt C, Stenquist B, Larko O, et al. Photodynamic therapy for acne
vulgaris: a pilot study of the dose-response and mechanism of action.
Acta Derm Venereol 2007; 87: 325-9.
230. Yin R, Hao F, Deng J, Yang XC, Yan H. Investigation of optimal amino-
laevulinic acid concentration applied in topical aminolaevulinic acid-
photodynamic therapy for treatment of moderate to severe acne: a pilot
study in Chinese subjects. Br J Dermatol 2010; 163: 1064-71.
231. Sakamoto FH, Tannous Z, Doukas AG, et al. Porphyrin distribution after
topical aminolevulinic acid in a novel porcine model of sebaceous skin.
Lasers Surg Med 2009; 41: 154-60.
232. Morton CA, Brown SB, Collins S, et al. Guidelines for topical photody-
namic therapy: report of a workshop of the British Photodermatology
Group. Br J Dermatol 2002; 146: 552-67.
233. Fabbrocini G, Di Costanzo MP, Riccardo AM, et al. Photodynamic ther-
apy with topical delta-aminolaevulinic acid for the treatment of plantar
warts. J Photochem Photobiol B 2001; 61: 30-4.
234. Smucler R, Jatsova E. Comparative study of aminolevulinic acid photo-
dynamic therapy plus pulsed dye laser versus pulsed dye laser alone in
treatment of viral warts. Photomed Laser Surg 2005; 31: 51-3.
235. Schroeter CA, Kaas L, Waterval JJ, et al. Successful treatment of periun-
gual warts using photodynamic therapy: a pilot study. J Eur Acad Der-
matol Venereol 2007; 21: 1170-4.
236. Fehr MK, Hornung R, Degen A, et al. Photodynamic therapy of vulvar
and vaginal condyloma and intraepithelial neoplasia using topically
applied 5-aminolevulinic acid. Lasers Surg Med 2002; 30: 273-9.
237. Stefanaki IM, Georgiou S, Themelis GC, et al. In vivo fl uorescence kinet-
ics and photodynamic therapy in condylomata acuminata. Br J Derma-
tol 2003; 149: 972-6.
238. Wang XL, Wang HW, Wang HS, et al. Topical 5-aminolaevulinic acid-
photodynamic therapy for the treatment of urethral condylomata acu-
minata. Br J Dermatol 2004; 151: 880-5.
239. Chen K, Chang BZ, Ju M, et al. Comparative study of photodynamic
therapy vs. CO2 laser vaporization in treatment of condylomata acumi-
nata: a randomized clinical trial. Br J Dermatol 2007; 156: 516-20.
240. Szeimies RM, Schleyer V, Moll I, et al. Adjuvant photodynamic therapy
does not prevent recurrence of condylomata acuminata after carbon
